„The World Health Organization (WHO) announced on Nov. 12, that it has prequalified Merck’s Ervebo as a vaccine for Ebola hemorrhagic fever.
Prequalification means that the Ervebo vaccine meets the “WHO standard for quality, safety and efficacy.”
“This is a historic step towards ensuring the people who most need it are able to access this life-saving vaccine,” WHO Director-General Dr. Tedros Adhanom Ghebreyesus said in the announcement. “Five years ago, we had no vaccine and no therapeutics for Ebola. With a prequalified vaccine and experimental therapeutics, Ebola is now preventable and treatable.”
History of Ebola
Ebola was discovered in 1976 during two simultaneous outbreaks, one in Sudan and the other in Zaire, now known as the Democratic Republic of Congo, along the Ebola River, which gave the disease its name.“ (…)